LeMaitre Vascular, Inc. — Earnings Quality Grade A
LMAT · Healthcare
Strong financial health
Screening Summary
Management Signals
Source: SEC EDGAR 8-K Item 5.02, with exhibit links when available
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 49 days, change -1 days YoY
AR growth 11.8% vs revenue growth 13.5%
Revenue 13.5%, CFFO 84.1%. Cash follows revenue
Expense Quality
Inventory 4.1% vs COGS 3.0%. Normal
CapEx growth -2.6% vs revenue 13.5%. Normal
SG&A/Gross Profit = 54.0%. Normal
Gross margin 71.5%, change +2.9pp. Stable
Cash Flow Quality
CFFO/NI = 1.41. Profits backed by cash
FCF $0.1B, FCF/NI = 1.29
Accruals ratio = -3.8%. Low accruals
Cash $0.4B covers debt $0.2B
Balance Sheet Health
Goodwill+Intangibles $0.1B = 25% of equity. Manageable
Debt/EBITDA = 2.0x. Healthy
Other assets 0.8% vs revenue 13.5%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -3% YoY. Normal
Manipulation Score
M-Score = -2.61 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25